NCT06609993

Brief Summary

The aim of this randomized trial is to assess the efficacy of analgesia using either thoracic epidural or intravenous infusions for open lumbar infrarenal aortic aneurys repair and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients received either preemptive thoracic epidural analgesia using either 0,2% ropivacaine with fentanyl or 0,2% bupivacaine with fenthanyl or preemptive intravenous infusion using metamizole and tramadol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2017

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
4.4 years until next milestone

First Submitted

Initial submission to the registry

August 23, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
Last Updated

September 24, 2024

Status Verified

September 1, 2024

Enrollment Period

2.3 years

First QC Date

August 23, 2024

Last Update Submit

September 19, 2024

Conditions

Keywords

Surgical Pleth Index (SPI)General Anaesthesia (GA),Numerical Pain Rating Scale (NPRS)Adequacy of Anaesthesia (AoA)metamizoletramadolthoracic epidural analgesiabupivacaineropivacaine

Outcome Measures

Primary Outcomes (1)

  • pain perception intraoperatively

    the investigators will compare the efficacy of preventive analgesia intraoperatively according to used preoperatively either intravenous or thoracic epidural infusions . The investigators will administer a rescue dose of fentanyl intravenously in a dose of 1 mcg per kg of body weight in the case when SPI (surgical pleth index) value increases over delta15 points in SPI scale every 5 minutes until SPI value decreases back to baseline value. Additionally, the investigators will analyse rescue fentanyl consumption in abovementioned groups

    from the skin incision till placement of last suture by the operator, an average of 2 hours

Secondary Outcomes (3)

  • pain perception postoperatively

    from extubation in the operating theatre until discharge to department of vascular surgery, but not shorter than half an hour

  • PONV (postoperative nausea and vomiting)

    48 hours

  • haemodynamic stability

    from the beginning of induction of anaesthesia till discharge to department of vascular surgery, on average several hours

Study Arms (3)

thoracic epidural analgesia using 0,2% ropicavaine with fentanyl

EXPERIMENTAL

preventive analgesia will be assured using 0,2% ropicavaine (Ropivacaini Hydrochloridum 1%, 10mg/mL, 10 mL, Molteni Farmaceutici, Italy) with fentanyl via thoracic epidural catheter perioperatively

Drug: intravenous rescue opioid analgesia using fentanylDrug: intravenous rescue atropine administrationDrug: intravenous rescue urapidil administrationDrug: intravenous rescue ephedrine administrationBiological: concentrate of red blood cellsBiological: red blood cells autotransfusionDrug: primary treatment of postoperative nausea and vomiting (PONV)Drug: secondary treatment of postoperative nausea and vomiting (PONV)Drug: intraopertative fluid challenge (IFC)Drug: postoperative rescue opioid analgesia using morphine

thoracic epidural analgesia using 0,2% bupicavaine with fentanyl

EXPERIMENTAL

preventive analgesia will be assured using 0,2% bupicavaine (Bupivacainum Hydrochloricum WZF 0.5%, 5 mg/mL, 10 mL, Polfa Warszawa S.A, Warsaw, Poland) with fentanyl via thoracic epidural catheter perioperatively

Drug: intravenous rescue opioid analgesia using fentanylDrug: intravenous rescue atropine administrationDrug: intravenous rescue urapidil administrationDrug: intravenous rescue ephedrine administrationBiological: concentrate of red blood cellsBiological: red blood cells autotransfusionDrug: primary treatment of postoperative nausea and vomiting (PONV)Drug: secondary treatment of postoperative nausea and vomiting (PONV)Drug: intraopertative fluid challenge (IFC)Drug: postoperative rescue opioid analgesia using morphine

intravenous analgesia using metamizole with tramadol

EXPERIMENTAL

preventive analgesia will be assured using intravenous infusion using metamizole 5 gram / 24 hours ((Pyralgin 0.5g/ml, 2 ml solution; Polpharma, Poland) with tramadol 400 mg/24h (50 mg/ml, 100 mg/2 ml solution; Polpharma, Poland) perioperatively

Drug: intravenous rescue opioid analgesia using fentanylDrug: intravenous rescue atropine administrationDrug: intravenous rescue urapidil administrationDrug: intravenous rescue ephedrine administrationBiological: concentrate of red blood cellsBiological: red blood cells autotransfusionDrug: primary treatment of postoperative nausea and vomiting (PONV)Drug: secondary treatment of postoperative nausea and vomiting (PONV)Drug: intraopertative fluid challenge (IFC)Drug: postoperative rescue opioid analgesia using morphine

Interventions

intraoperative rescue opioid analgesia using 1mcg/kg of fentanyl (Fentanyl WZF, POlfa Warsawa, Poland) )/ body weight when SPI value \> 15 baseline

Also known as: IROA-F
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

atropine (Atropinum Sulfuricum WZF, POlfa Warsawa, Poland) in a dose of 0,5mg/kg of will be administered intravenously when heart rate \< 50

Also known as: IRAA
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

urapidil (Ebrantil 25, Takeda PHARMA, Japan) in a dose of 10 mg will be administered intravenously when DAP \> 110 mmHg or SAP \> 200 mmHg

Also known as: IRUA
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

ephedrine (Ephedrinum Sulfuricum WZF, POlfa Warsawa, Poland) in a dose of 10 mg will be administered intravenously when DAP \< 50 mmHg or MAP \< 65 mmHg

Also known as: IREA
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

concentrate of red blood cells will be transfused when concentration of haemoglobin \< 10g%

Also known as: RBC
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

red blood cells from the operation site will be retransfused using cell saver

Also known as: cell saver
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

dexamethasone ((Dexaven 4mg/ml, Jelfa, Poland) in a dose of 4 mg will be administered intravenously when incidence of PONV is observed

Also known as: primary treatment of PONV
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

Ondansetron (Ondansetron Accord 2mg/ml, 2 ml solution, Accord Healthcare Limited, Great Britain) in a dose of 4 mg will be administered intravenously when incidence of persistent PONV is observed despite the dexamethasone in a dose of 4 mg will be administration intravenously

Also known as: treatment of persistent PONV
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

3 mililitre of synthetic colloid will be transfused intravenously per each sudden blood loss of 1 mililitre

Also known as: IFC
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

postoperative rescue opioid analgesia will be administered intravenously using 2 miligrams of morphine ((Morfini Sulfas WZF, 20mg/ml, solutio pro iniectione, Polfa Warszawa, Poland)every 10 minutes until postoperative pain perception using NPRS scale will decrease below 4 (NPRS; 0 meant no pain and 10 meant the worst pain imaginable)

Also known as: PROA-M
intravenous analgesia using metamizole with tramadolthoracic epidural analgesia using 0,2% bupicavaine with fentanylthoracic epidural analgesia using 0,2% ropicavaine with fentanyl

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • written consent to participate in the study
  • written consent to undergo general anaesthesia combined with different techniques of pre-emptive intravenous or thoracic epidural analgesia for aortic aneurysm repair

You may not qualify if:

  • antiplatelet therapy
  • allergy to local anaesthetics, metamizole or tramadol
  • necessity of administration of vasoactive drugs influencing SPI monitoring

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Silesia

Sosnowiec, Silesian Voivodeship, 41-200, Poland

Location

Related Publications (8)

  • Laferriere-Langlois P, Morisson L, Jeffries S, Duclos C, Espitalier F, Richebe P. Depth of Anesthesia and Nociception Monitoring: Current State and Vision For 2050. Anesth Analg. 2024 Feb 1;138(2):295-307. doi: 10.1213/ANE.0000000000006860. Epub 2024 Jan 12.

    PMID: 38215709BACKGROUND
  • Hung KC, Huang YT, Kuo JR, Hsu CW, Yew M, Chen JY, Lin MC, Chen IW, Sun CK. Elevated Surgical Pleth Index at the End of Surgery Is Associated with Postoperative Moderate-to-Severe Pain: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2022 Sep 6;12(9):2167. doi: 10.3390/diagnostics12092167.

    PMID: 36140567BACKGROUND
  • Won YJ, Oh SK, Lim BG, Kim YS, Lee DY, Lee JH. Effect of surgical pleth index-guided remifentanil administration on perioperative outcomes in elderly patients: a prospective randomized controlled trial. BMC Anesthesiol. 2023 Feb 17;23(1):57. doi: 10.1186/s12871-023-02011-5.

    PMID: 36803564BACKGROUND
  • Oh SK, Won YJ, Lim BG. Surgical pleth index monitoring in perioperative pain management: usefulness and limitations. Korean J Anesthesiol. 2024 Feb;77(1):31-45. doi: 10.4097/kja.23158. Epub 2023 Mar 17.

    PMID: 36926752BACKGROUND
  • Ledowski T, Burke J, Hruby J. Surgical pleth index: prediction of postoperative pain and influence of arousal. Br J Anaesth. 2016 Sep;117(3):371-4. doi: 10.1093/bja/aew226.

    PMID: 27543532BACKGROUND
  • Jain N, Gera A, Sharma B, Sood J, Chugh P. Comparison of Surgical Pleth Index-guided analgesia using fentanyl versus conventional analgesia technique in laparoscopic cholecystectomy. Minerva Anestesiol. 2019 Apr;85(4):358-365. doi: 10.23736/S0375-9393.18.12954-3. Epub 2019 Jan 2.

    PMID: 30605991BACKGROUND
  • Gold MS, Rockman CB, Riles TS. Comparison of lumbar and thoracic epidural narcotics for postoperative analgesia in patients undergoing abdominal aortic aneurysm repair. J Cardiothorac Vasc Anesth. 1997 Apr;11(2):137-40. doi: 10.1016/s1053-0770(97)90202-0.

    PMID: 9105981BACKGROUND
  • Ball L, Pellerano G, Corsi L, Giudici N, Pellegrino A, Cannata D, Santori G, Palombo D, Pelosi P, Gratarola A. Continuous epidural versus wound infusion plus single morphine bolus as postoperative analgesia in open abdominal aortic aneurysm repair: a randomized non-inferiority trial. Minerva Anestesiol. 2016 Dec;82(12):1296-1305. Epub 2016 Aug 30.

    PMID: 27575452BACKGROUND

MeSH Terms

Conditions

Aortic AneurysmPostoperative Nausea and VomitingPain, Postoperative

Interventions

Operative Blood Salvage

Condition Hierarchy (Ancestors)

AneurysmVascular DiseasesCardiovascular DiseasesAortic DiseasesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomitingPainNeurologic Manifestations

Intervention Hierarchy (Ancestors)

Tissue and Organ HarvestingTransplantationSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator, Department of Anaesthesiology and Intensive Therapy

Study Record Dates

First Submitted

August 23, 2024

First Posted

September 24, 2024

Study Start

December 12, 2017

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

September 24, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations